<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-30T19:44:43Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/4543" metadataPrefix="marc">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/4543</identifier><datestamp>2022-12-19T11:19:05Z</datestamp><setSpec>com_10259_3924</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>com_10259_4354</setSpec><setSpec>col_10259_3925</setSpec><setSpec>col_10259_4355</setSpec></header><metadata><record xmlns="http://www.loc.gov/MARC21/slim" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
<leader>00925njm 22002777a 4500</leader>
<datafield tag="042" ind1=" " ind2=" ">
<subfield code="a">dc</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Pertejo Fernández, Pablo</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Corres, Nazaret</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Torroba Pérez, Tomás</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">García Valverde, María</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="260" ind1=" " ind2=" ">
<subfield code="c">2015-02-06</subfield>
</datafield>
<datafield tag="520" ind1=" " ind2=" ">
<subfield code="a">Enantiopure 3-carboxamide-1,4-benzodiazepin-5-ones were synthesized via the Ugi reaction followed by the Staudinger/aza-Wittig or reduction reactions in only two steps. A complete reversal of diastereoselectivity was achieved depending on the cyclization methodology employed. The different orientation of the C3 substituent in our 3-substituted 1,4-benzodiazepin-5-ones with respect to the most studied 1,4-benzodiazepin-2-ones makes them complementary in the development of new drugs because the primary source of binding selectivity of 1,4-benzodiazepines is the selective recognition of ligand conformations by the receptor.</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">1523-7060</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">http://hdl.handle.net/10259/4543</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">10.1021/ol503628r</subfield>
</datafield>
<datafield tag="245" ind1="0" ind2="0">
<subfield code="a">Reversal of diastereoselectivity in the synthesis of Peptidomimetic 3‑Carboxamide-1,4-benzodiazepin-5-ones</subfield>
</datafield>
</record></metadata></record></GetRecord></OAI-PMH>